Webdisclosure.com

Search

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)
17/03/2023 22:45
Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting
Lire la news
Voir tous les communiqués de Relief Therapeutics Holdings AG
RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)
16/03/2023 07:00
Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe
Lire la news
Voir tous les communiqués de Relief Therapeutics Holdings AG
RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)
15/03/2023 07:00
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™ 
Lire la news
Voir tous les communiqués de Relief Therapeutics Holdings AG
RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)
28/02/2023 07:00
Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars
Lire la news
Voir tous les communiqués de Relief Therapeutics Holdings AG
RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)
14/02/2023 07:00
Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa
Lire la news
Voir tous les communiqués de Relief Therapeutics Holdings AG
RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)
08/02/2023 07:00
Relief Therapeutics Provides an Update on its Financing Strategy
Lire la news
Voir tous les communiqués de Relief Therapeutics Holdings AG
RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)
17/01/2023 06:56
Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
Lire la news
Voir tous les communiqués de Relief Therapeutics Holdings AG
RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)
27/12/2022 07:15
Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission
Lire la news
Voir tous les communiqués de Relief Therapeutics Holdings AG
RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)
27/12/2022 07:00
Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders
Lire la news
Voir tous les communiqués de Relief Therapeutics Holdings AG
RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)
20/12/2022 07:00
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements
Lire la news
Voir tous les communiqués de Relief Therapeutics Holdings AG

©Dissemination technology Webdisclosure.com - copyright 2023 SYMEX ECONOMICS all rights reserved